Rifaximin Delayed Release for the Prevention of Recurrent Acute Diverticulitis and Diverticular Complications.
Clinical trial NCT03469050 · TERMINATED
Trial details
- NCT number
- NCT03469050
- Sponsor
- Alfasigma S.p.A.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-02
- Primary completion
- 2020-12-22
- Enrollment
- 193
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.